Marsh & McLennan Companies, Inc. (MRSH)
NYSE • Currently up 0.26 (+0.14%) in today's trading session
1 member of Congress has disclosed 1 trade in Marsh & McLennan Companies, Inc. (MRSH) via STOCK Act filings. The most recent disclosure was a sale by Kevin Hern on 24 August 2026. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).
Marsh & McLennan Companies, Inc. is currently trading at $187.84, positioned at 61% of its 52-week range ($156.60 – $207.83).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
Marsh & McLennan Companies, Inc. Price History and Technical Analysis
Congressional Trading Activity for MRSH
| Kevin Hern | 24 Aug 2026 | 1 Sept 2026 | Sale | Stock | $1,001 - $15,000 | N/A |
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about MRSH
- Which members of Congress have traded MRSH?
- 1 member of Congress has disclosed 1 trade in Marsh & McLennan Companies, Inc. (MRSH) under the STOCK Act: Kevin Hern.
- When was MRSH most recently disclosed by Congress?
- The most recent MRSH disclosure was a sale by Kevin Hern on 24 August 2026.
- What is the total disclosed congressional trading volume for MRSH?
- Members of Congress have disclosed approximately $8K in MRSH sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in MRSH?
- This MRSH page updates as soon as new STOCK Act disclosures are filed for Marsh & McLennan Companies, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track MRSH in Congress
See when politicians buy or sell this stock